标题
Systemic treatment of HCC in special populations
作者
关键词
Hepatocellular carcinoma, Transplant, HIV, Autoimmune diseases, Diabetes, Metabolic syndrome, Fibrolamellar, Mixed HCC/CCC, Child-Pugh B, Elderly, Haemodialysis, Vascular invasion
出版物
JOURNAL OF HEPATOLOGY
Volume 74, Issue 4, Pages 931-943
出版商
Elsevier BV
发表日期
2020-11-26
DOI
10.1016/j.jhep.2020.11.026
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
- (2020) TEIJI KUZUYA et al. ANTICANCER RESEARCH
- Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2
- (2020) Masatoshi Kudo et al. LIVER INTERNATIONAL
- International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis
- (2020) Álvaro Díaz‐González et al. LIVER INTERNATIONAL
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review
- (2020) E. Klajer et al. SEMINARS IN ONCOLOGY
- Patterns of Comorbidity in Hepatocellular Carcinoma: A Network Perspective
- (2020) Xiao-Min Mu et al. International Journal of Environmental Research and Public Health
- Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection
- (2020) Maria Gonzalez-Cao et al. JAMA Oncology
- Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer
- (2020) Shingo Miyamoto et al. JAMA Oncology
- O-8 Atezolizumab + bevacizumab vs sorafenib for unresectable hepatocellular carcinoma: Results from older adults enrolled in IMbrave150
- (2020) D. Li et al. ANNALS OF ONCOLOGY
- SO-9 Outcomes for patients with advanced hepatocellular carcinoma and Child-Pugh B liver function in the phase 3 CELESTIAL study of cabozantinib vs placebo
- (2020) A. El-Khoueiry et al. ANNALS OF ONCOLOGY
- Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
- (2020) Sakti Chakrabarti et al. Cancers
- Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
- (2020) Katharina Pomej et al. Cancers
- Liver damage related to immune checkpoint inhibitors
- (2019) Naoshi Nishida et al. Hepatology International
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre
- (2019) Friedrich Foerster et al. United European Gastroenterology Journal
- Association between overall survival and adverse events with lenvatinib treatment in patients with hepatocellular carcinoma (REFLECT).
- (2019) Max W. Sung et al. JOURNAL OF CLINICAL ONCOLOGY
- Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status.
- (2019) Masatoshi Kudo et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
- (2019) Ruidong Xue et al. CANCER CELL
- Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma
- (2019) Lorenza Rimassa et al. CANCER TREATMENT REVIEWS
- Lenvatinib for the treatment of HCC: A single institute experience.
- (2019) San-Chi Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
- (2019) Thomas Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial.
- (2019) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Update on hepatocellular carcinoma: Pathologists’ review
- (2019) Tony El Jabbour et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
- (2019) Massimo Iavarone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
- (2019) Victor Cunha et al. Annals of Hepatology
- REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
- (2019) Tatsuya Yamashita et al. JOURNAL OF GASTROENTEROLOGY
- Cancer patients with potential eligibility for vascular endothelial growth factor antagonists use have an increased risk for cardiovascular diseases comorbidities
- (2019) Fei Liu et al. JOURNAL OF HYPERTENSION
- Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
- (2019) Jian Zhou et al. Annals of Hepatology
- Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching
- (2019) Toshifumi Tada et al. HEPATOLOGY RESEARCH
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
- (2019) Neil J. Shah et al. Journal for ImmunoTherapy of Cancer
- Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease
- (2018) Noha Abdel-Wahab et al. ANNALS OF INTERNAL MEDICINE
- Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2018) Jong Hwan Choi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
- (2018) François-Xavier Danlos et al. EUROPEAN JOURNAL OF CANCER
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
- (2018) Giulia C. Leonardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
- (2018) Supriya G. Mohile et al. JOURNAL OF CLINICAL ONCOLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibrolamellar Carcinoma: A Concise Review
- (2018) Chun-Chieh Lin et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).
- (2018) Lorenza Rimassa et al. JOURNAL OF CLINICAL ONCOLOGY
- Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis
- (2018) Alberto Zanetto et al. TRANSPLANT INTERNATIONAL
- Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis
- (2018) Mairéad Geraldine McNamara et al. EUROPEAN JOURNAL OF CANCER
- Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study
- (2018) David J. Pinato et al. JOURNAL OF CLINICAL ONCOLOGY
- Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
- (2018) Aline Mähringer-Kunz et al. LIVER INTERNATIONAL
- State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma
- (2018) Agnieszka Anysz-Grodzicka et al. Current Medical Imaging Reviews
- Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey
- (2017) Takashi Kokudo et al. HEPATOLOGY
- Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
- (2017) Kim A. Reiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma
- (2017) Brian D. Friend et al. PEDIATRIC BLOOD & CANCER
- Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis
- (2017) Hidenori Toyoda et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
- (2017) Jack P. Silva et al. HPB
- Hepatocellular carcinoma in patients with HIV
- (2017) Imane El Dika et al. Current Opinion in HIV and AIDS
- Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma
- (2017) Andrew X. Zhu et al. JAMA Oncology
- Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases
- (2016) Guadalupe Garcia-Tsao et al. HEPATOLOGY
- Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma
- (2016) Suguru Yamashita et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
- (2016) Jorge A. Marrero et al. JOURNAL OF HEPATOLOGY
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- FDA Approval Summary: Ramucirumab for Gastric Cancer
- (2015) S. J. Casak et al. CLINICAL CANCER RESEARCH
- Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
- (2015) Andrea Mancuso et al. DIGESTIVE AND LIVER DISEASE
- Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
- (2015) Andrea Casadei Gardini et al. EXPERT OPINION ON PHARMACOTHERAPY
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
- (2015) Nicola de’Angelis WORLD JOURNAL OF GASTROENTEROLOGY
- Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
- (2014) G. Sapisochin et al. ANNALS OF SURGICAL ONCOLOGY
- Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors
- (2014) Julien Edeline et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis
- (2014) Manabu Morimoto et al. HEPATOLOGY RESEARCH
- Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey
- (2014) E Rosenthal et al. HIV MEDICINE
- Designing Therapeutic Clinical Trials for Older and Frail Adults With Cancer: U13 Conference Recommendations
- (2014) Arti Hurria et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
- (2014) J. N. Honeyman et al. SCIENCE
- Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
- (2014) P. De Simone et al. TRANSPLANTATION PROCEEDINGS
- Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- (2013) S. Schlesinger et al. ANNALS OF ONCOLOGY
- Coagulation in Liver Disease: A Guide for the Clinician
- (2013) Patrick G. Northup et al. Clinical Gastroenterology and Hepatology
- Risk of Hepatobiliary Cancer After Solid Organ Transplant in the United States
- (2013) Jill Koshiol et al. Clinical Gastroenterology and Hepatology
- Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10
- (2013) Tobias Eggert et al. GUT
- Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer
- (2013) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
- (2012) H.-S. Shiah et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients
- (2012) Massimiliano Berretta et al. ANTI-CANCER DRUGS
- Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
- (2012) Arndt Weinmann et al. DIGESTIVE AND LIVER DISEASE
- Primary biliary cirrhosis and cancer risk: A systematic review and meta-analysis
- (2012) Yan Liang et al. HEPATOLOGY
- Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies
- (2012) Austin Duffy et al. HEPATOLOGY
- High Incidence of Hepatocellular Carcinoma in ESRD Patients: Caused by High Hepatitis Rate or 'Uremia'? A Population-based Study
- (2012) J.-C. Hwang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Resection of Pulmonary Metastases from Hepatocellular Carcinoma following Liver Transplantation
- (2012) Shin Hwang et al. WORLD JOURNAL OF SURGERY
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib
- (2011) Manabu Morimoto et al. HEPATOLOGY RESEARCH
- Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study
- (2011) Qing Zhang et al. INVESTIGATIONAL NEW DRUGS
- Increasing burden of liver disease in patients with HIV infection
- (2011) Deepak Joshi et al. LANCET
- Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
- (2011) Carlos Gomez-Martin et al. LIVER TRANSPLANTATION
- Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat Hard
- (2011) M. Berretta et al. ONCOLOGIST
- Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse
- (2010) R. K. Jain et al. CLINICAL CANCER RESEARCH
- Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
- (2009) Antonius A. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
- (2009) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence and Risk Factors for Hepatocellular Carcinoma After Solid Organ Transplantation
- (2008) Christopher J. Hoffmann et al. TRANSPLANTATION
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma
- (2007) Gregory C. Connolly et al. THROMBOSIS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started